Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(37)
Paul S. Mischel
5
Antoni Ribas
4
Erika Maria von Euw (Erika María von Euw)
4
Narsis Attar
4
Roger S. Lo
4
Journals
(4)
J TRANSL MED
3
PNAS
1
PLOS One
1
Cell Cycle
1
Keywords
(45)
Embed
Subscribe
Academic
Authors
Deliang Guo
Deliang Guo,University of California Los Angeles,Medicine,Cell Biology
Edit
Deliang Guo
University of California Los Angeles
Publications:
7
|
Citations:
48
Fields:
Medicine
,
Cell Biology
View FAQ about top research areas and Fields of study
Collaborated with
37 co-authors
from 2007 to 2011
|
Cited by
277 authors
Cumulative
Annual
Sort by:
Publications
(7)
BibTeX
|
RIS
|
RefWorks
Download
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
(
Citations: 1
)
Franziska Niehr
,
Erika von Euw
,
Narsis Attar
,
Deliang Guo
,
Doug Matsunaga
,
Hooman Sazegar
,
Charles Ng
,
John A Glaspy
,
Juan A Recio
,
Roger S Lo
,
Paul S Mischel
,
Begonya Comin-Anduix
http://academic.research.microsoft.com/io.ashx?type=5&id=48626111&selfId1=25681469&selfId2=0&maxNumber=12&query=
Journal:
Journal of Translational Medicine - J TRANSL MED
, vol. 9, no. 1, pp. 1-13, 2011
Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway
Mohammad Atefi
,
Erika von Euw
,
Narsis Attar
,
Charles Ng
,
Connie Chu
,
Deliang Guo
,
Ramin Nazarian
,
Bartosz Chmielowski
,
John A. Glaspy
,
Begonya Comin-Anduix
,
Paul S. Mischel
,
Roger S. Lo
http://academic.research.microsoft.com/io.ashx?type=5&id=57401019&selfId1=25681469&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 6, no. 12, 2011
Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032
(
Citations: 10
)
Jonas N Søndergaard
,
Ramin Nazarian
,
Qi Wang
,
Deliang Guo
,
Teli Hsueh
,
Stephen Mok
,
Hooman Sazegar
,
Laura E MacConaill
,
Jordi G Barretina
,
Sarah M Kehoe
,
Narsis Attar
,
Erika von Euw
http://academic.research.microsoft.com/io.ashx?type=5&id=30218822&selfId1=25681469&selfId2=0&maxNumber=12&query=
Journal:
Journal of Translational Medicine - J TRANSL MED
, vol. 8, no. 1, 2010
Regulation of Endothelial Cell Cycle by Laminar Versus Oscillatory Flow Distinct Modes of Interactions of AMP-Activated Protein Kinase and Akt Pathways
(
Citations: 7
)
Deliang Guo
,
Shu Chien
,
John Y.-J. Shyy
Published in 2010.
Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032
Jonas N Søndergaard
,
Ramin Nazarian
,
Qi Wang
,
Deliang Guo
,
Teli Hsueh
,
Stephen Mok
,
Hooman Sazegar
,
Laura E MacConaill
,
Jordi G Barretina
,
Sarah M Kehoe
,
Narsis Attar
,
Erika von Euw
http://academic.research.microsoft.com/io.ashx?type=5&id=48009512&selfId1=25681469&selfId2=0&maxNumber=12&query=
Journal:
Journal of Translational Medicine - J TRANSL MED
, vol. 8, no. 1, pp. 1-11, 2010
Sort by:
Citations
(48 times by 48 publications)
Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring V600EBRAF
(
Citations: 1
)
F Xing
,
Y Persaud
,
C A Pratilas
,
B S Taylor
,
M Janakiraman
,
Q-B She
,
H Gallardo
,
C Liu
,
T Merghoub
,
B Hefter
,
I Dolgalev
,
A Viale
http://academic.research.microsoft.com/io.ashx?type=5&id=56651283&selfId1=25681469&selfId2=0&maxNumber=12&query=
Journal:
Oncogene
, vol. 31, no. 4, pp. 446-457, 2012
Inhibition of Soluble Epoxide Hydrolase Attenuates High-Fat-Diet–Induced Hepatic Steatosis by Reduced Systemic Inflammatory Status in Mice
Yan Liu
,
Huaixin Dang
,
Dan Li
,
Wei Pang
,
Bruce D. Hammock
,
Yi Zhu
Journal:
PLOS One
, vol. 7, no. 6, 2012
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
Journal:
Nature Reviews Cancer - NAT REV CANCER
, vol. 12, no. 3, pp. 159-169, 2012
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
(
Citations: 1
)
Franziska Niehr
,
Erika von Euw
,
Narsis Attar
,
Deliang Guo
,
Doug Matsunaga
,
Hooman Sazegar
,
Charles Ng
,
John A Glaspy
,
Juan A Recio
,
Roger S Lo
,
Paul S Mischel
,
Begonya Comin-Anduix
http://academic.research.microsoft.com/io.ashx?type=5&id=48626111&selfId1=25681469&selfId2=0&maxNumber=12&query=
Journal:
Journal of Translational Medicine - J TRANSL MED
, vol. 9, no. 1, pp. 1-13, 2011
Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway
Mohammad Atefi
,
Erika von Euw
,
Narsis Attar
,
Charles Ng
,
Connie Chu
,
Deliang Guo
,
Ramin Nazarian
,
Bartosz Chmielowski
,
John A. Glaspy
,
Begonya Comin-Anduix
,
Paul S. Mischel
,
Roger S. Lo
http://academic.research.microsoft.com/io.ashx?type=5&id=57401019&selfId1=25681469&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 6, no. 12, 2011
Comments